First in class, best in class or a wild card: who will dominate the anti-obesity medication market?

IF 1.9 4区医学 Q3 HEALTH CARE SCIENCES & SERVICES

Journal of comparative effectiveness research Pub Date : 2024-07-01 Epub Date: 2024-05-29 DOI:10.57264/cer-2024-0044

Emma Collins, Alice Beattie, Sreeram V Ramagopalan, Jonathan Pearson-Stuttard

引用次数: 0

查看原文本刊更多论文

同类第一、同类最佳，还是一枝独秀：谁将主导抗肥胖药物市场？

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of comparative effectiveness research HEALTH CARE SCIENCES & SERVICES-

CiteScore

3.50

自引率

9.50%

发文量

121

期刊介绍： Journal of Comparative Effectiveness Research provides a rapid-publication platform for debate, and for the presentation of new findings and research methodologies. Through rigorous evaluation and comprehensive coverage, the Journal of Comparative Effectiveness Research provides stakeholders (including patients, clinicians, healthcare purchasers, and health policy makers) with the key data and opinions to make informed and specific decisions on clinical practice.